Project ideas from Hacker News discussions.

The main thing about P2P meth is that there's so much of it (2021)

📝 Discussion Summary (Click to expand)

Top 4themes in the discussion

Theme Summary Representative quote
1. The pseudo‑ephedrine ban is largely ineffective and fuels a black market Users point out that restricting OTC sales only drives the market underground, raises prices, and doesn’t curb meth use. “Fantastic write up. I think the biggest takeaway for me is just how insanely ineffective banning pseudoephedrine over the counter was.” — SV_BubbleTime
2. Prohibition creates higher‑potency substitutes (the “iron law of prohibition”) Bans push producers toward more concentrated forms (e.g., P₂P meth) and make the illicit market more lucrative. “yes, the ‘Iron law of prohibition’” — trhway
3. Analogous harms from previous deregulation (opioid crisis) When drugs are made widely available through legal channels, usage and overdose deaths can surge dramatically. “Famously, the US spent about 15‑20 years attempting this with opioids… The result? A shattering drug addiction crisis that at its height killed more people annually than the entire Vietnam War.” — hash872
4. Harm‑reduction and regulated access are preferred to outright prohibition Regulation, quality control, and supervised use are argued to reduce overall societal harm more than blanket bans. “I believe harm reduction is the answer. There are people who will be curious to try substances no matter what you do.” — LoganDark

🚀 Project Ideas

RegiMed Pulse

Summary

  • Real‑time monitoring of OTC and prescription drug restrictions to prevent sudden shortages for patients needing meds like pseudoephedrine or ADHD stimulants.
  • Alerts users and pharmacies when legal purchase limits change, reducing surprise stockouts.

Details

Key Value
Target Audience Patients requiring regulated meds, pharmacists, prescribers
Core Feature Automated policy feed with shortage alerts and purchase‑limit tracking
Tech Stack React, Node.js, PostgreSQL, WebSockets, FDA/EMA API integrations
Difficulty Medium
Monetization Revenue-ready: Subscription $19/mo per pharmacy/plan

Notes

  • HN commenters repeatedly cite the frustration of “the ephedrine ban” and “ADHD medication shortage” with no warning; a proactive alert system would directly address that pain. - Could spark discussion on public‑health policy transparency and create a network for sharing scarcity data across regions.

PseudoEpi Map

Summary

  • Interactive map showing current over‑the‑counter purchase limits, stock levels, and legal pharmacies for pseudoephedrine and similar decongestants.
  • Helps users locate compliant retailers instantly, avoiding wasted trips and black‑market risk.

Details

Key Value
Target Audience Consumers, pharmacists, pharmacy chains
Core Feature Geo‑based inventory and limit dashboard with real‑time updates
Tech Stack Python/Django, Mapbox, PostgreSQL, Pharmacy chain APIs
Difficulty Low
Monetization Revenue-ready: 2% transaction fee on each verified purchase link

Notes

  • Many HN users lament “you still need to buy it from behind the counter and give ID” and the “limited amount per month” hassle; a transparent map would make compliance easier and reduce illicit workarounds.
  • Potential for community‑driven data sharing and discussion on policy effectiveness.

ContamCheck

Summary

  • Smartphone‑based app that analyzes cheap portable spectrometers or user‑uploaded lab reports to flag contaminants in meth, cocaine, or other stimulants. - Generates anonymized contaminant reports to inform users and public‑health officials.

Details| Key | Value |

|-----|-------| | Target Audience | Drug‑checking NGOs, users, harm‑reduction groups | | Core Feature | Contaminant detection via AI‑enhanced spectral analysis and crowdsourced reporting | | Tech Stack | React Native, TensorFlow Lite, Flask backend, SQLite | | Difficulty | High | | Monetization | Hobby |

Notes

  • Directly addresses the discussion point that “the evidence we have is against the idea of contaminants” and the desire for better purity data; a tool that actually measures contaminants would be highly valued.
  • Could foster user‑generated safety data and policy advocacy.

SafeScript

Summary

  • Curated platform connecting patients with licensed clinicians for low‑dose, medically supervised prescriptions of controlled stimulants (e.g., amphetamine, methylphenidate) while enforcing KYC and usage monitoring.
  • Reduces black‑market demand by providing legitimate access with built‑in dosage limits.

Details

Key Value
Target Audience Patients seeking legitimate ADHD/narcolepsy treatment, regulators
Core Feature Tele‑health prescription pathway with dosing caps, compliance tracking, and pharmacy fulfillment
Tech Stack Next.js, Express, HL7/FHIR APIs, Stripe for payments
Difficulty Medium
Monetization Revenue-ready: $30 per prescription license fee

Notes

  • Mirrors complaints about “shortage of ADHD medication” and “government should regulate purity” while highlighting the need for a controlled, prescription‑only channel that satisfies both safety and access concerns.
  • Sparks debate on regulated access vs. outright prohibition, likely to generate HN discussion.

Read Later